首页> 外文期刊>Peptides: An International Journal >Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.
【24h】

Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.

机译:HLA-DR分子的免疫抑制肽片段的二聚可增强其效力。

获取原文
获取原文并翻译 | 示例
       

摘要

Our previous studies revealed that the nonapeptide fragment of HLA-DR molecule, located in the beta chain 164-172 with the VPRSGEVYT sequence, suppresses the immune responses. The sequence is located on the exposed molecule loop, therefore it may be involved in the interactions with other proteins. We suggested that the loop may serve as a functional epitope on the HLA class II surface for intermolecular binding, and that possible mechanism of biological action of the synthesized peptides is associated with interfering of adhesion of HLA class II molecules to their coreceptors. It has been postulated that oligomerization of the coreceptors is required for stable binding to class II HLA. Based on the crystal dimeric structure of HLA-DR molecules, we designed, and synthesized molecules able to induce the putative coreceptors dimerization. The synthesized series of compounds consisted of two VPRSGEVYT sequences linked through their C-termini by spacers of different length: (VPRSGEVYTGn)2K-NH2 ( n = 4-6). The results demonstrate that the dimerization of the nonapeptide fragment of HLA-DR results in enhanced immunosuppressory properties.
机译:我们以前的研究表明,HLA-DR分子的九肽片段位于具有VPRSGEVYT序列的β链164-172中,可抑制免疫应答。该序列位于暴露的分子环上,因此它可能参与与其他蛋白质的相互作用。我们建议,该环可能充当HLA II类表面上用于分子间结合的功能性表位,并且合成肽的生物学作用的可能机理与HLA II类分子与其共受体的粘附有关。据推测,为了与II类HLA稳定结合,需要共受体的低聚。基于HLA-DR分子的晶体二聚体结构,我们设计并合成了能够诱导假定的共受体二聚体的分子。合成的一系列化合物由两个VPRSGEVYT序列组成,两个VPRSGEVYT序列通过其C末端通过不同长度的间隔子连接:(VPRSGEVYTGn)2K-NH2(n = 4-6)。结果表明,HLA-DR的非肽片段的二聚化导致增强的免疫抑制特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号